| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |